COVID-19 Impact On Life Science Research and Clinical Diagnostic Labs
Updates on the impact of COVID-19 on drug discovery life science labs and diagnostics. Based on weekly and bi-weekly trackers, US drug discovery life science and diagnostics labs answer questions regarding the impact of COVID-19 on their operations.
How is the current COVID-19 Crisis affecting labs across the country and in California? How are life science research labs and clinical labs faring?
Topics Covered:
• Lab Closure Time & Ramp Up Expectations
• Lab Focus
• Economic Impact & Change in Spending
• Overall Worry
• Overall Impact
• Impact on Volume of Tests
• Support Needed by Infectious Disease Labs
• Demographics
Results of COVID-19 Lab Tracker
Kalorama Information discusses the Clinical Diagnostics MasterFile and answer questions such as:
- What are some typical use cases for the Clinical Diagnostics MasterFile?
- How is the data sourced and how reliable is it?
- Which modalities are covered and how many sites are included?
The Kalorama Information Clinical Diagnostics MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities
